Mutations at the SLC20A2 gene and brain resilience in families with idiopathic basal ganglia calcification ("Fahr's disease")

Frontiers in Human Neuroscience

Volumn , Issue JUL, 2013, Pages

  de Oliveira, Danyllo F ^a   de Lemos, Roberta R ^a   de Oliveira, João R M ^a  

^a FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Fahr's Disease; Penetrance; Phosphate; Resilience; SCL20A2

Indexed keywords

AMINO ACID SEQUENCE; ARTICLE; BRAIN FUNCTION; BRAIN RESILIENCE; FAHR DISEASE; GENE EXPRESSION; GENE MUTATION; GENETIC ASSOCIATION; GENETIC DAMAGE; GENETIC HETEROGENEITY; GENETIC VARIABILITY; HAPLOINSUFFICIENCY; HETEROZYGOTE; HUMAN; LINKAGE ANALYSIS; MOLECULAR DYNAMICS; MUTATOR GENE; NONHUMAN; PENETRANCE; PHENOTYPE; PROTEIN FOLDING; SLC20A2 GENE;

EID: 84933678922     PISSN: 16625161     EISSN: 16625161     Source Type: Journal    
DOI: 10.3389/fnhum.2013.00420     Document Type: Article

References (12)

1. Argylean, M., Carbon, M., Niethammer, M., Ulug, A.M., Voss, H.U., Bressman, S.B., Dhawan, V., and Eildeberg, D. (2009). Cerebellothalamocortical connectivity regulates Penetrance in dystonia. J. Neurosci. 31, (9740). 9747.
2. Burga, A., Casanueva, O. M., and Lehner, B. (2011). Predicting mutation outcome from early stochastic variation in genetic interaction partners. Nature 7376, 250-253.
3. Geschwind, D.H., Loginov, M., and Stern, J.M. (1999). Identification of a locus on chromosome 14q for idiopathic basal ganglia calcification (Fahr's Disease). A.J. Hum. Genet. 65, 764-672.
4. Hsu, S.C., Sears, R.L., Lemos, R. R et al. (2013). Mutations in SLC20A2 are a major cause of familial idiopathic basal ganglia calcification. Neurogenetics. 2013 Jan 20. [Epub ahead of print]
5. Lemos, R.R., Oliveira, M.F., Oliveira, J.R.M. (2013). Reporting a new mutation at the SLC20A2 gene in familial idiopathic basal ganglia calcification. European Journal of Neurology (In press).
6. Lemos, R.R., Oliveira, D. F., Zatz, M., and Oliveira, J.R.M. (2011). Population and computational analysis of the P521A MGEA6 variation as a risk factor for idiopathic basal ganglia calcification (Fahr's Disease). J. Mol. Neurosci. 43, 333-336.
7. Manyam, B. (2005). What is and what is not 'Fahr's Disease'. Parkinsonism. Relat. Disord. 11, 73-80.
8. Nicolas, G., Pottier, C., Maltête D et al. (2013). Mutation of the PDGFRB gene as a cause of idiopathic basal ganglia calcification. Neurology. 2, 181-187.
9. Oliveira, J.R.M., Hopfer, S., Papp J et al. (2003). A genome wide scan for familial idiopathic basal ganglia calcification (Fahr's disease) identifies new candidate regions and confirms genetic heterogeneity. Am. J. Hum. Genet. 5, 570
10. Villa-Bellosta, R., and Sorribas, V. (2011). Calcium Phosphate Deposition with Normal Phosphate Concentration-Role of Pyrophosphate-Circ. J. 75, 2705-2710.
11. Villa-Bellosta, R., Ravera, S., Sorribas, V., Stange, G., Levi, M., Murer, H., Biber, J., and Forster, I.C. (2009). The Na-Pi cotransporter PiT-2 (SLC20A2) is expressed in the apical membrane of rat renal proximal tubules and regulated by dietary Pi. Am. J. Physiol. Renal Physiol. 296, 691-699.
12. Wang, C., Li, Y., Shi, L., Ren, Jie., Patti, M. et al. (2012). Mutations of SLC20A2 link familial idiopathic basal ganglia calcification with phosphate homeostasis. Nat. Genet. 44, 254-256.